The course is aimed at surgeons, biologists and biomedical laboratory health technicians for a total of 80 participants.
The course aims to provide participants with an updated characterization of PD-L1 expression in non-small cell lung cancer (NSCLC) including the examination of future markers predictive of response to immunotherapy.
Participation in the course requires the issue of a certificate of participation from the Campus Bio-Medico University of Rome and the ECM certificate with a consideration of 4 credits.
